Written by Klarity Editorial Team
Published: Mar 19, 2026

If you’re a psychiatrist or PMHNP thinking about launching an ADHD-focused telehealth practice — or scaling the one you’ve got — you’re dealing with a unique set of operational realities that most content glosses over. ADHD isn’t just another telepsychiatry niche. The regulatory landscape is messier (Schedule II prescribing), the patient population is trickier to retain (hello, no-shows), and the economics don’t work like other specialties unless you build your systems right.
This isn’t a motivational post about ‘the future of digital mental health.’ It’s a practical breakdown of what actually matters when you’re running an ADHD telehealth operation: multi-state licensing headaches, controlled substance compliance, patient acquisition costs that can sink your margins, and the cash-pay versus insurance calculus that determines whether you’re working for yourself or working for your clearinghouse.
Let’s walk through what works, what doesn’t, and what nobody tells you until you’re six months in and wondering why your schedule has more holes than patients.
Here’s the non-negotiable truth: You need a full medical license in every state where your patient is physically located during the visit. There’s no ‘telehealth exception.’ California doesn’t care that you’re calling from New York — if your patient is sitting in their San Diego apartment, you need a California license to treat them legally.
For psychiatrists, the Interstate Medical Licensure Compact (IMLC) is your best friend — if you’re practicing in the right states. As of 2025, 37 states plus DC and Guam participate, including Florida (joined 2024), Texas (2021), Pennsylvania (2016), and Illinois (2015). The compact lets you apply once and fast-track licenses across member states, usually cutting processing time from 4-6 months down to 4-6 weeks once you have your Letter of Qualification.
The problem: California and New York — two of the biggest telehealth markets — are not compact members.
California’s licensure process is notoriously slow (budget 6+ months and prepare for exhaustive documentation requirements). New York is faster (6-8 weeks typically) but still requires a traditional application. If you want to serve patients in those states, you’re filing separately and waiting.
For PMHNPs, it’s even messier. The APRN Compact exists but only 4 states had adopted it by mid-2024 — it’s essentially irrelevant for most providers right now. You’re getting individual state NP licenses the old-fashioned way. And in states like California and Texas, you’ll still need physician supervision or a collaborative practice agreement to prescribe, which adds another operational layer (and cost) to your practice.
The DEA piece: Every state where you prescribe controlled substances requires a DEA registration for that state ($888 for 3 years per registration). Some states — like Illinois — also require a separate state-controlled substance license on top of your DEA registration. It’s not expensive, but it’s another hoop and another processing delay you need to factor into your timeline.
What this means for your practice: If you’re starting out, pick your states strategically. Florida’s Telehealth Provider Registration is a rare gem — out-of-state providers can register (not get full licensure) to treat Florida patients via telehealth, and the state carved out an exception allowing Schedule II prescribing for psychiatric conditions. That means you can serve Florida ADHD patients without going through the full licensing gauntlet, as long as you’re treating a psychiatric disorder (which ADHD qualifies as).
Texas, Pennsylvania, and Illinois are all IMLC-friendly and have high demand due to provider shortages. If you’re building a multi-state practice, start there. Save California for when you have the cash flow and patience to wait half a year for the privilege of treating patients in one of the most overregulated states for provider licensing.
ADHD treatment is medication management, and ADHD medications are almost exclusively Schedule II controlled substances — amphetamine salts (Adderall), methylphenidate (Ritalin, Concerta), lisdexamfetamine (Vyvanse). That means your entire practice is built on prescribing medications the DEA watches closely and states regulate heavily.
The Ryan Haight Act (2008) was supposed to block telemedicine prescribing of Schedule II drugs without an in-person exam. During COVID, the DEA waived that requirement. As of late 2024, those flexibilities have been extended through 2025, allowing you to prescribe stimulants via audio-visual telehealth without seeing the patient face-to-face first.
What happens in 2026? Nobody knows for sure, but the DEA has proposed a ‘special registration’ system that may require some providers to conduct periodic in-person evaluations for patients on long-term controlled substances. If that rule goes into effect, it could fundamentally change the economics of pure-play telehealth ADHD practices. You might need to partner with local clinics for in-person check-ins, or limit your practice to states where you can realistically see patients in person once a year.
State-level variation makes this even more complicated:
Every state requires PDMP checks before prescribing controlled substances. California’s CURES, Texas’s TxPAT, Illinois PMP, Florida’s E-FORCSE — you’re logging into a separate database for every patient in every state before writing a script. If you’re practicing across multiple states, you need a workflow (or an EHR that integrates PDMP checks) to make this manageable, or you’ll spend half your day on compliance paperwork.
Bottom line: ADHD telehealth is still legally viable through 2025, but you need to stay on top of DEA rulemaking and have a contingency plan for 2026. If you’re building a practice that depends entirely on remote prescribing with zero in-person contact, you’re taking a regulatory risk. Diversify your model or establish relationships with local providers who can do periodic physical exams if the rules tighten.
One of the first strategic decisions you’ll make is whether to take insurance or go cash-only. For ADHD specifically, the economics favor cash-pay more than almost any other psychiatric specialty, but it’s not a slam dunk.
Direct-pay psychiatry is growing fast. Patients are willing to pay out-of-pocket for faster access and less bureaucracy, and providers love the simplicity. You set your fee (say, $200 for an initial eval, $100 for follow-ups), the patient pays, and you’re done. No claim filing, no waiting 60 days for reimbursement, no fighting with Cigna over whether a 90-day Adderall prescription is ‘medically necessary.’
The upside: You control everything. You can offer 60-minute initial evaluations instead of the 20 minutes insurance reimburses. You can prescribe what’s clinically appropriate without worrying about formularies or prior authorizations. You can structure creative care models — some ADHD practices charge a monthly membership fee ($100-150/month) that includes unlimited messaging and one visit, which patients love for predictability.
Cash-pay also lets you avoid the 25-40% revenue hit that comes with insurance contracts. If an insurer reimburses $75 for a med check visit, but you can charge $125 privately, you’re making 67% more per appointment. Over a full schedule, that difference is the margin between barely breaking even and actually building wealth.
The downside: You’re limiting your patient pool to people who can afford $100-200 per visit out-of-pocket. That works great in affluent markets (suburban professionals, tech workers, college students whose parents pay), but it excludes working-class patients and anyone relying on insurance benefits.
And here’s the kicker: ADHD is chronic. Patients need monthly or quarterly follow-ups indefinitely. A cash-only model works if your patients have the means and motivation to keep paying. If they don’t, they’ll drop out and find an in-network provider, and you’ll spend more on patient acquisition to replace them.
Taking insurance opens the floodgates. Patients search their provider directory, see you’re in-network, and book. Your schedule fills faster because cost isn’t a barrier (they’re paying a $20 co-pay, not $150 cash).
The upside: Volume. If you’re a new practice trying to get to 20+ patients per week, insurance panels get you there faster than cash-only marketing. Insurance also improves adherence — patients who only pay a co-pay are more likely to keep showing up than those paying full freight.
The downside: Administrative hell. Prior authorizations for ADHD meds are common (especially for brand-name stimulants or non-stimulant options like Strattera or Qelbree). That’s unpaid staff time — or your time — filling out forms to justify a prescription to someone at UnitedHealthcare who’s never met your patient.
Insurance also pays less. A 15-minute follow-up med check might reimburse $70-90 depending on the plan. If you’re in a high-volume model (four patients per hour), that’s $280-360/hour gross. Sounds decent until you subtract overhead, no-show losses, billing costs, and the time you spend on the phone with pharmacy benefit managers.
Reimbursement rates vary wildly by state and payer. In states with good Medicaid reimbursement (like New York or Massachusetts), taking Medicaid can be viable. In states where Medicaid pays $40 for a med check (looking at you, Texas), it’s not worth the hassle unless you’re mission-driven.
Some providers split the difference: stay out-of-network, charge cash rates, but provide patients with a superbill they can submit to their insurance for out-of-network reimbursement. This works if your patients have PPO plans with decent OON benefits. They pay you upfront, you give them a detailed receipt with CPT codes, and they get reimbursed 50-70% by their insurer.
This model lets you charge what you’re worth while still offering patients some insurance benefit. It’s popular in markets like New York and California where patients expect to use insurance but are willing to pay more for faster access or a specific provider.
What works for ADHD? If you’re starting out and need patient volume, take insurance for the first 12-18 months to fill your schedule. Once you’re at capacity, you can choose: either drop insurance panels and go cash-only (or out-of-network), or stay paneled but be selective about which plans you accept. Some providers keep Medicare and one or two commercial plans (like Aetna or Anthem) and drop the rest.
The key is don’t try to be everything to everyone. Mixing cash and insurance patients in the same practice creates billing headaches and patient confusion. Pick a lane and optimize for it.
Here’s the uncomfortable truth: ADHD patients no-show at significantly higher rates than the general population. A 2024 study out of the UK found that 38% of adults with ADHD missed at least one appointment per year (compared to 23% of non-ADHD peers), and 16% missed multiple appointments annually.
This isn’t just annoying — it’s expensive. A no-show is a lost appointment slot you can’t fill last-minute. If you’re billing $100 per visit and you have a 15% no-show rate across 80 appointments per month, that’s $1,200 in lost revenue monthly, or $14,400 annually. For a solo provider, that’s real money.
ADHD symptoms — inattention, disorganization, time blindness — directly contribute. Patients forget appointments, mix up times, or get distracted and miss reminders. It’s not malicious; it’s literally symptomatic. Add in the fact that many ADHD patients are younger adults (18-30) who are still figuring out life logistics, and you’ve got a recipe for inconsistent attendance.
The operational impact goes beyond revenue. When an ADHD patient no-shows a med check, they may run out of medication, which can trigger urgent calls, requests for emergency refills, or worse — patients buying stimulants from friends or going without and decompensating. You end up spending more time managing the fallout from a no-show than you would have spent on the appointment.
1. Automated reminders (multiple touchpoints). One reminder 24 hours out isn’t enough. Send an email and text 48 hours before, another text the morning of, and a final ‘your appointment starts in 30 minutes’ notification. Some EHRs and telehealth platforms (like SimplePractice or Doxy.me) have built-in reminder systems with multiple escalations.
2. Make them ADHD-friendly. Bold the date and time. Include an ‘Add to Calendar’ button. Keep the message short — ADHD brains tune out long blocks of text.
3. Same-day confirmation. Some practices have staff (or a VA) call or text every patient the morning of their appointment: ‘Hey, just confirming you’re still good for 2pm today?’ This catches people who forgot and lets you fill the slot if they cancel.
4. Implement a no-show policy (and enforce it). For cash-pay patients, charge the full session fee for no-shows without 24-hour notice. For insurance patients (where you usually can’t charge), make it clear that after 2-3 no-shows, you’ll discharge them from the practice. Sounds harsh, but chronic no-shows disrupt your practice and prevent other patients from accessing care.
5. Telehealth helps (but isn’t a silver bullet). Research shows telehealth reduces no-show rates compared to in-person visits — no travel barrier, no parking, no waiting room. But you still need reminders. The ease of telehealth can also make patients more casual about canceling (‘it’s just a video call’), so you can’t assume it solves the problem entirely.
6. Shorter booking windows. Instead of scheduling follow-ups 3 months out, keep a waitlist and book appointments 2-4 weeks in advance. The closer the appointment, the less likely patients are to forget or have schedule conflicts.
7. Overbooking (use cautiously). Some providers overbook by 10-15% to account for expected no-shows. If you historically have a 10% no-show rate, book 11 patients in 10 slots. This is risky — if everyone shows, you’re scrambling — but it’s how some high-volume practices stay efficient.
The bottom line: No-shows are a structural challenge in ADHD care, not something you can eliminate entirely. Build systems that minimize them (reminders, policies, telehealth) and price them into your economics. If you’re charging $100 per visit but losing 15% to no-shows, you’re effectively earning $85 per scheduled slot. Plan accordingly.
Filling your schedule is the difference between a thriving practice and a money pit. There are two dominant models for acquiring ADHD patients in telehealth: pay-per-appointment platforms and subscription/DIY marketing. Each has a place, but most providers misunderstand the economics.
Platforms like Zocdoc operate on a pay-per-booking model: you pay a fee each time a new patient books an appointment through the platform. Fees vary by specialty and location, but for psychiatry, expect $50-180 per new patient booking. That fee is charged whether the patient shows up or not (though some platforms waive it if the patient cancels within a few hours).
The upside: Instant patient flow. You list your profile, and patients searching ‘ADHD psychiatrist near me’ find you immediately. For a new practice, this is rocket fuel — you can go from zero to a full schedule in weeks instead of months.
The downside: It’s expensive at scale. If you’re paying $100 per booking and half of those patients no-show or never return, your effective acquisition cost for a retained patient is $200+. Do that 20 times per month and you’re spending $2,000-4,000 on patient acquisition. Over a year, that’s $24,000-48,000 — money that could have gone into your pocket or into building your own marketing.
There’s also a loyalty problem. Patients who find you through a marketplace often view providers as interchangeable. They booked because you had an open slot, not because they researched you or were referred by someone they trust. Retention can be lower because they didn’t invest much effort in choosing you.
This model involves paying a fixed monthly fee for visibility — either a directory listing, a marketing agency on retainer, or a telehealth platform membership. For example, some regional psychiatric networks charge $100-300/month for a provider listing. Marketing agencies might charge $500-2,000/month to run Google Ads and manage your SEO.
The upside: Predictable costs. If you pay $500/month and acquire 10 new patients, your cost per acquisition is $50. If you acquire 20 patients next month, it drops to $25. The marginal cost per patient decreases as your practice grows, which is the opposite of pay-per-appointment.
You also own the relationship. Patients come through your website or a referral source, not a marketplace. They chose you specifically, which often means better retention and higher lifetime value.
The downside: It takes time and expertise. SEO takes 6-12 months to yield results. Google Ads for ‘ADHD psychiatrist [city]’ can cost $15-40 per click, and most clicks don’t convert to booked appointments — a realistic cost per booked patient through PPC is $200-400+ when you account for wasted spend.
If you’re not experienced in digital marketing (or don’t have the budget to hire someone who is), you’ll waste money. A lot of solo providers spend $1,500/month on a marketing agency for 6 months and get 3 new patients to show for it because the targeting was off or the website didn’t convert.
This is where platforms like Klarity Health differentiate themselves. Instead of making you gamble on marketing spend or pay per booking through a marketplace, Klarity uses a pay-per-appointment model but with a critical difference: you only pay when you actually see a qualified patient, not just when someone books.
The value prop is simple: no upfront marketing spend, no monthly subscription fees, no wasted ad spend on clicks that don’t convert. Klarity handles patient acquisition, matches patients to your specialty and availability, and you pay a standard listing fee per new patient appointment. It’s economically similar to Zocdoc’s model, but Klarity’s platform includes the telehealth infrastructure (no need for a separate Zoom subscription or EHR), supports both insurance and cash-pay patients, and focuses on pre-qualifying patients so you’re not wasting time on no-shows or patients who aren’t a good fit.
Why this matters for ADHD providers: Patient acquisition is one of the biggest hidden costs in building a telehealth practice. If you’re spending $3,000-5,000/month on marketing with uncertain results, you’re taking on risk and cash flow pressure. Platforms that charge only when you see a patient remove that risk entirely. You get guaranteed ROI — the cost of acquiring the patient is known, and you control your schedule so you only pay when you’re ready to see more patients.
Compare that to DIY marketing: you could eventually build a practice that acquires patients for $50-100 each if you nail your SEO and referral strategy over 18-24 months. But most solo providers don’t have the expertise, budget, or patience to pull that off. They burn through savings paying a marketing agency that underdelivers, or they spend nights and weekends trying to figure out Google Ads while their schedule stays half-empty.
The smart play: Use a platform like Klarity or Zocdoc to fill your schedule quickly (accepting the higher per-patient cost as a known expense), while simultaneously building your own long-term marketing (website, SEO, referral relationships with PCPs and schools). Over 12-18 months, your owned channels start generating patients, and you can reduce your reliance on paid platforms. But don’t try to do it all yourself from day one unless you have deep pockets and a high tolerance for uncertainty.
Let’s talk real numbers, because most ‘how to start a telehealth practice’ content either lowballs the costs (to make it sound easy) or inflates them (to sell you something).
Licensing and credentialing:
If you’re launching in 3 states, budget $3,000-5,000 just for licensing and DEA in year one, plus another $3,000-5,000 for malpractice. That’s $6,000-10,000 before you see your first patient.
Technology and infrastructure:
Ballpark: $2,000-5,000 upfront for tech setup, $150-400/month for software subscriptions.
Marketing and patient acquisition:
The smart move for a new practice: start with a platform that charges per appointment (zero upfront marketing spend) and allocate $500-1,000/month to start building your owned marketing presence (website, content, local referrals). Avoid burning $3,000/month on Google Ads unless you know what you’re doing.
Legal and business formation:
Total first-year startup costs (solo provider, 2-3 states): $15,000-30,000 if you’re conservative and use platforms to avoid big marketing spend. If you try to go all-in on custom tech and big ad budgets, it can easily hit $50,000-75,000, which is overkill unless you’re venture-backed.
Can I prescribe Adderall via telehealth in 2026?Yes, as long as you’re licensed in the state where the patient is located and follow that state’s telemedicine and controlled substance rules. The federal DEA extension allows telehealth prescribing of Schedule II stimulants through 2025 without an in-person exam. What happens in 2026 depends on final DEA rulemaking, so stay updated.
Do I need a separate license for every state where I treat ADHD patients?Yes. Telehealth doesn’t bypass state licensing laws. If you’re treating a patient in Texas, you need a Texas license (or Florida’s special telehealth registration if treating FL patients). The IMLC helps if you’re in member states, but CA and NY require traditional applications.
How do I reduce no-shows in my ADHD practice?Use multiple automated reminders (text and email 48 hours, 24 hours, and 2 hours before appointments). Implement a no-show policy with fees for cash-pay patients or discharge after repeat no-shows for insurance patients. Consider same-day confirmation calls and keep booking windows shorter (2-4 weeks instead of 3 months).
Should I take insurance or go cash-only for ADHD patients?If you’re new and need volume, take insurance for 12-18 months to fill your schedule. Once at capacity, you can transition to cash-only or out-of-network if your market supports it. Cash-pay offers better margins and less admin, but limits your patient pool. Insurance brings more patients but lower reimbursement and prior auth headaches.
What’s the real cost to acquire an ADHD patient through marketing?DIY marketing (SEO, Google Ads, directories) typically costs $200-500+ per booked patient when you factor in all costs — agency fees, ad spend, staff time, no-show rates, and months of investment before results. Pay-per-appointment platforms charge $50-180 per booking but deliver immediate patient flow. Platforms like Klarity that charge per appointment (not per click) remove the risk of wasted marketing spend.
Is Klarity Health worth it for ADHD providers?If you want to avoid upfront marketing costs and guaranteed patient flow, yes. You only pay when you see a qualified patient, the platform includes telehealth infrastructure, and you control your schedule. It’s a smart choice for new providers or those scaling without gambling on expensive marketing channels. The trade-off is you pay per patient instead of building your own brand from day one, but you can do both simultaneously.
The operational reality of ADHD telehealth is more complex than most content admits. Multi-state licensing is a gauntlet. Controlled substance rules are in flux. No-shows will cost you more than you expect. And patient acquisition is expensive if you’re doing it wrong.
But the opportunity is real. Demand for ADHD care is surging. Telehealth makes it possible to serve patients across state lines (with the right licenses). And the economics work — if you build smart systems, price appropriately, and avoid the common traps that sink new practices.
If you want to skip the trial-and-error phase and start seeing ADHD patients without burning $5,000/month on marketing that might not work, consider joining Klarity Health’s provider network. You get pre-qualified patients, built-in telehealth infrastructure, and a pay-per-appointment model that removes the financial risk of patient acquisition. No upfront costs. No wasted ad spend. Just qualified patients matched to your specialty and schedule.
Explore Klarity Health’s provider platform and see if it’s a fit for your practice. Or keep building your own patient pipeline — either way, now you know what actually matters.
University of Bath. (July 9, 2024). ‘New study reveals high rates of missed GP appointments among patients with ADHD.’ https://www.bath.ac.uk/announcements/new-study-reveals-high-rates-of-missed-gp-appointments-among-patients-with-adhd/
Mirage News. (July 10, 2024). ‘Research Finds High ADHD Patient No-Show Rates.’ https://www.miragenews.com/research-finds-high-adhd-patient-no-show-rates-1271911/
Zocdoc. (December 17, 2025). ‘How Zocdoc’s Pay-Per-Booking Model Works.’ https://www.zocdoc.com/blog/facts/pay-per-booking-fees-explained/
PatientGain. (2023-2024). ‘Zocdoc Pricing Analysis.’ https://www.patientgain.com/zocdoc-pricing
PsychMD Georgia. (June 3, 2025). ‘Direct Psychiatry vs Insurance-Based Care: What’s the Difference?’ https://psychmdga.org/blog/direct-psychiatry-vs-insurance-based-care-whats-the-difference/
Find the right provider for your needs — select your state to find expert care near you.